Vigilant Biosciences, Inc.

Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection of oral cancer. Our point–of–care solution is simple, accurate† and cost–effective–empowering clinicians to improve potential outcomes through earlier intervention. Vigilant Biosciences’ innovative BeVigilant™ RAPID Test is based on patented technology that detects specific protein markers clinically shown to be associated with early stage cancers.